NMS-026 - Early positive signals for new treatments of primary hypercholesterolemia and mixed dyslipidemia: Bempedoic acid and inclisiran in Spain

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: NMS-026
• By: JIMENEZ-SERRANIA, Maria-Isabel (Miguel De Cervantes European University (UEMC), Spain)
• Co-author(s): Prof Maria-Isabel Jimenez-Serrania (Miguel De Cervantes European University (UEMC), Valladolid, Spain)
  Ms Sara-Maria Martinez-Gonzalez (Miguel De Cervantes European University (UEMC), Valladolid, Spain)
  
• Abstract:

  Introduction: Primary hypercholesterolemia and mixed dyslipidemia are common conditions that often require lipid-lowering therapies. New treatments such as bempedoic acid and inclisiran have recently been approved in combination with diet, with statins, or with other lipid-lowering drugs in patients with hypercholesterolemia, mixed dyslipidemia,..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login